Tour de France Winner Flunks Drug Test
Floyd Landis tested positive for high levels of testosterone, which Landis claims is either a mistake or the result of natural bodily processes. He was tested after his near-superhuman comeback win on an Alpine stage of the race, which the New York Times called perhaps the greatest single-day push in Tour history. If this accusation proves true, Wheaties may have to find a new cover boy.
Floyd Landis tested positive for high levels of testosterone, which Landis claims is either a mistake or the result of natural bodily processes. He was tested after his near-superhuman comeback win on an Alpine stage of the race, which the New York Times called perhaps the greatest single-day push in Tour history.
If this accusation proves true, Wheaties may have to find a new cover boy.
Your support matters…AP:
Tour de France champion Floyd Landis tested positive for high levels of testosterone during the race, his Phonak team said Thursday on its Web site.
The statement came a day after the UCI, cycling’s world governing body, said an unidentified rider had failed a drug test during the Tour.
And the statement came just four days after Landis stood on the victory podium on the Champs-Elysees, succeeding seven-time winner Lance Armstrong as an American winner in Paris.
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Book Excerpt
In 2019, more than 500,000 Americans were arrested for cannabis-related charges, the vast majority for simple possession.
TD Original
Veterans who trusted MAPS with their trauma have made allegations of manipulation and deceit.
Americas
Narco-messages are fairly common, and just as often, not sincere.
Opinion
From psychedelic pharma executives endorsing non-consensual dosing, to a major advocacy group failing to acquire informed consent from trial participants, there is evidence of a serious lack of understanding of consent in the psychedelics industry.
Military
The notion of psychedelic treatment as a “reset” for the brain has become exceedingly popular, but the expectations instilled by this type of language can be harmful to patients.
Military
In recent years, active-duty Marines have taken an apparent interest in using LSD.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.